BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28450990)

  • 1. [Anatomopathological profile of breast cancer in cape bon, Tunisia].
    Sahraoui G; Khanchel F; Chelbi E
    Pan Afr Med J; 2017; 26():11. PubMed ID: 28450990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and anatomopathological profile of breast cancer in the region of North-West of Tunisia.
    Mahjoub N; Ben Salem K; Mokrani A; Mansouri H; Achouri L; Chraiet N; Fehri R
    Tunis Med; 2021 Avril; 99(4):441-448. PubMed ID: 35244929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
    Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of pathological features in Her-2 overexpressing breast carcinomas: A single institution experience in southern Tunisia.
    Charfi S; Toumi N; Triki S; Kallel R; Kebaïli S; Chaabane K; Khabir A; Daoud J; Frikha M; Boudawara TS
    Breast Dis; 2015; 35(4):233-9. PubMed ID: 26397770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series.
    Sassi F; Rekaya MB; Belarbi A; Chilla D; Mansouri N; Achouri L; Saied E; Kassa R; Kacem LB; Ouezani M; Debabeche N; Rebhi F; Rammeh S
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1818. PubMed ID: 37092543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.
    Ayadi L; Khabir A; Amouri H; Karray S; Dammak A; Guermazi M; Boudawara T
    World J Surg Oncol; 2008 Oct; 6():112. PubMed ID: 18945339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Ki67 and clinicopathological features in breast cancer].
    Wang B; Wang X; Wang J; Xuan L; Wang Z; Wang X; Gao J; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):273-5. PubMed ID: 24989913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer.
    Pathmanathan N; Balleine RL; Jayasinghe UW; Bilinski KL; Provan PJ; Byth K; Bilous AM; Salisbury EL; Boyages J
    J Clin Pathol; 2014 Mar; 67(3):222-8. PubMed ID: 24403187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70years or older treated for breast cancer twenty years apart.
    Montroni I; Rocchi M; Santini D; Ceccarelli C; Ghignone F; Zattoni D; Nuvola G; Zanotti S; Ugolini G; Taffurelli M
    J Geriatr Oncol; 2014 Jul; 5(3):260-5. PubMed ID: 24661771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pure colloid carcinoma of the breast: anatomoclinical study of seven cases].
    Chtourou I; Makni SK; Bahri I; Abbes K; Sellami A; Fakhfakh I; Gouiaa N; Ayadi L; Frikha M; Daoud J; Boudawara TS
    Cancer Radiother; 2009 Jan; 13(1):37-41. PubMed ID: 18703371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
    Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
    Wo JY; Taghian AG; Nguyen PL; Raad RA; Sreedhara M; Bellon JR; Wong JS; Gadd MA; Smith BL; Harris JR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):188-96. PubMed ID: 20171798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.
    Crabb SJ; Cheang MC; Leung S; Immonen T; Nielsen TO; Huntsman DD; Bajdik CD; Chia SK
    Clin Breast Cancer; 2008 Jun; 8(3):249-56. PubMed ID: 18650155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
    Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
    Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.